Series B - PanOptica
Investment Firm
Overview
PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.
Announced Date
Apr 15, 2014
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Dan Burgess |
 Novo Ventures |
 Third Rock Ventures |
Round Details and Background
PanOptica raised $45000000 on 2014-04-15 in Series B
PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 06, 2017 |  Series B - PanOptica | 2 | - | 11.0M |
| Jan 07, 2016 | Series B - PanOptica | 1 | - | undefined |
| May 27, 2016 | Series B - PanOptica | 3 | - | 23.9M |
| Jan 04, 2011 | Series A - PanOptica | 3 | - | 30.0M |
Recent Activity
There is no recent news or activity for this profile.